BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27639968)

  • 21. Atherosclerosis neovascularization and imaging.
    Purushothaman KR; Sanz J; Zias E; Fuster V; Moreno PR
    Curr Mol Med; 2006 Aug; 6(5):549-56. PubMed ID: 16918375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractal dimension and directional analysis of elastic and collagen fiber arrangement in unsectioned arterial tissues affected by atherosclerosis and aging.
    Mostaço-Guidolin LB; Smith MSD; Hewko M; Schattka B; Sowa MG; Major A; Ko AC
    J Appl Physiol (1985); 2019 Mar; 126(3):638-646. PubMed ID: 30629475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerosis and extracellular matrix.
    Katsuda S; Kaji T
    J Atheroscler Thromb; 2003; 10(5):267-74. PubMed ID: 14718743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology.
    Evans NR; Tarkin JM; Chowdhury MM; Warburton EA; Rudd JH
    Curr Atheroscler Rep; 2016 Jun; 18(6):30. PubMed ID: 27108163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques.
    Lee SJ; Paeng JC
    Korean J Radiol; 2015; 16(5):955-66. PubMed ID: 26357491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET and SPECT imaging of apoptosis in vulnerable atherosclerotic plaques with radiolabeled Annexin A5.
    Laufer EM; Winkens HM; Corsten MF; Reutelingsperger CP; Narula J; Hofstra L
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):26-34. PubMed ID: 19182725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basic components of connective tissues and extracellular matrix: elastin, fibrillin, fibulins, fibrinogen, fibronectin, laminin, tenascins and thrombospondins.
    Halper J; Kjaer M
    Adv Exp Med Biol; 2014; 802():31-47. PubMed ID: 24443019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
    Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
    Mol Imaging; 2014; 13():. PubMed ID: 24757762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging of atherosclerosis.
    Takx RA; Partovi S; Ghoshhajra BB
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):5-12. PubMed ID: 26239134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-invasive molecular imaging of vulnerable atherosclerotic plaques.
    Magnoni M; Ammirati E; Camici PG
    J Cardiol; 2015 Apr; 65(4):261-9. PubMed ID: 25702846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 68Ga-Glutamate Carboxypeptidase II Ligand Positron Emission Tomography for Clinical Molecular Imaging of Atherosclerotic Plaque Neovascularization.
    Derlin T; Thiele J; Weiberg D; Thackeray JT; Püschel K; Wester HJ; Aguirre Dávila L; Larena-Avellaneda A; Daum G; Bengel FM; Schumacher U
    Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2213-2219. PubMed ID: 27609368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elastin fragmentation and atherosclerosis progression: the elastokine concept.
    Maurice P; Blaise S; Gayral S; Debelle L; Laffargue M; Hornebeck W; Duca L
    Trends Cardiovasc Med; 2013 Aug; 23(6):211-21. PubMed ID: 23561795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging.
    Furer V; Fayad ZA; Mani V; Calcagno C; Farkouh ME; Greenberg JD
    Semin Arthritis Rheum; 2012 Apr; 41(5):676-88. PubMed ID: 22000818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What are the most useful and trustworthy noninvasive anatomic markers of existing vascular disease?
    Chow BJ; Veinot JP
    Curr Cardiol Rep; 2006 Nov; 8(6):439-45. PubMed ID: 17059796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancements in non-invasive imaging of atherosclerosis: Future perspectives.
    Guimarães J; de Almeida J; Mendes PL; Ferreira MJ; Gonçalves L
    J Clin Lipidol; 2024; 18(2):e142-e152. PubMed ID: 38142178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional imaging of atherosclerosis to advance vascular biology.
    Sakalihasan N; Michel JB
    Eur J Vasc Endovasc Surg; 2009 Jun; 37(6):728-34. PubMed ID: 19232504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. F-18 Fluoride Positron Emission Tomography-Computed Tomography for Detecting Atherosclerotic Plaques.
    Kang WJ
    Korean J Radiol; 2015; 16(6):1257-61. PubMed ID: 26576114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current techniques for MR imaging of atherosclerosis.
    Balu N; Wang J; Dong L; Baluyot F; Chen H; Yuan C
    Top Magn Reson Imaging; 2009 Aug; 20(4):203-15. PubMed ID: 20805731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular imaging of atheroslerotic plaque with nuclear medicine techniques.
    Schillaci O; Danieli R; Padovano F; Testa A; Simonetti G
    Int J Mol Med; 2008 Jul; 22(1):3-7. PubMed ID: 18575769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.